Stock-Based Compensation (Details) (USD $) | 3 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | 3 Months Ended | 6 Months Ended | | | | 6 Months Ended | |
In Thousands, except Share data, unless otherwise specified | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | Mar. 31, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2013 | Dec. 31, 2013 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2014 | 31-May-14 | Apr. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 |
| Stock Options | Stock Options | Stock Options | Stock Options | Stock Options | Stock Options | Restricted Shares | Restricted Shares | Restricted Shares | Restricted Shares | 2000 Employee Option Plan | 2009 Employee Option Plan | 2009 Employee Option Plan | 2009 Employee Option Plan | 2000 Employee Option Plan and 2009 Employee Option Plan | 2004 Directors Option Plan | 2012 Directors Restricted Stock Plan |
Share-based Compensation Arrangement by Share-based Payment Award | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of additional stock options that can be granted (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | ' | ' | ' | ' | ' | ' |
Common Stock reserved for issuance | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 29,000,000 | 16,000,000 | ' | ' | ' |
Shares available for the granting of additional stock options | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 12,401,170 | ' | ' | ' | 70,000 | 85,961 |
Options ratable vesting period | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '5 years | '3 years | ' |
Options exercisable period | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '10 years | '10 years | ' |
Number of additional stock options expected to be granted (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | ' |
Expense incurred for stock-based compensation plans (in dollars) | $9,973 | $8,890 | $19,249 | $17,175 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Expense incurred for stock-based compensation plans, net of tax (in dollars) | 7,333 | 6,473 | 14,137 | 12,503 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock option activity | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Options outstanding at the beginning of the period (in shares) | ' | ' | ' | ' | 13,088,300 | 13,422,226 | ' | 13,422,226 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Options granted (in shares) | ' | ' | ' | ' | 3,023,500 | 32,500 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Options exercised (in shares) | ' | ' | ' | ' | -1,128,975 | -314,966 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Options forfeited (in shares) | ' | ' | ' | ' | -49,560 | -51,460 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Options outstanding at the end of the period (in shares) | ' | ' | ' | ' | 14,933,265 | 13,088,300 | ' | 14,933,265 | ' | 13,422,226 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Vested and non-vested options expected to vest at the end of the period (in shares) | ' | ' | ' | ' | 13,478,241 | ' | ' | 13,478,241 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Exercisable at the end of the period (in shares) | ' | ' | ' | ' | 6,616,375 | ' | ' | 6,616,375 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted Average Exercise Price | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average exercise price, options outstanding at the beginning of the period (in dollars per share) | ' | ' | ' | ' | $52.14 | $51.80 | ' | $51.80 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average exercise price, options granted (in dollars per share) | ' | ' | ' | ' | $95.44 | $89.13 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average exercise price, options exercised (in dollars per share) | ' | ' | ' | ' | $39.80 | $40.41 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average exercise price, options forfeited (in dollars per share) | ' | ' | ' | ' | $65.22 | $59.80 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average exercise price, options outstanding at the end of the period (in dollars per share) | ' | ' | ' | ' | $61.79 | $52.14 | ' | $61.79 | ' | $51.80 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average exercise price, vested and non-vested options expected to vest (in dollars per share) | ' | ' | ' | ' | $60.92 | ' | ' | $60.92 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average exercise price, exercisable (in dollars per share) | ' | ' | ' | ' | $45.58 | ' | ' | $45.58 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted Average Remaining Contractual Term | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average remaining contractual term of options outstanding | ' | ' | ' | ' | '7 years 5 months 16 days | '6 years 10 months 20 days | ' | ' | ' | '7 years 29 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average remaining contractual term of options vested options and non-vested expected to vest | ' | ' | ' | ' | '7 years 4 months 13 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average remaining contractual term of options exercisable | ' | ' | ' | ' | '5 years 11 months 5 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Aggregate Intrinsic Value | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Aggregate intrinsic value of options outstanding (in dollars) | ' | ' | ' | ' | 515,908 | 517,164 | ' | 515,908 | ' | 501,706 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Aggregate intrinsic value of options, vested and non-vested options expected to vest (in dollars) | ' | ' | ' | ' | 477,353 | ' | ' | 477,353 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Aggregate intrinsic value of options exercisable (in dollars) | ' | ' | ' | ' | 335,874 | ' | ' | 335,874 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Status of the Company's non-vested options and changes during the year | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Non-vested options at the beginning of the period (in shares) | ' | ' | ' | ' | 7,990,961 | 8,016,921 | ' | 8,016,921 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Non-vested options, options granted (in shares) | ' | ' | ' | ' | 3,023,500 | 32,500 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Non-vested options, options vested (in shares) | ' | ' | ' | ' | -2,648,011 | -7,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Non-vested options, options forfeited (in shares) | ' | ' | ' | ' | -49,560 | -51,460 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Non-vested options at the end of the period (in shares) | ' | ' | ' | ' | 8,316,890 | 7,990,961 | ' | 8,316,890 | ' | 8,016,921 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted Average Fair Value at Grant Date | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average fair value at the grant date, options outstanding at the beginning of the period (in dollars per share) | ' | ' | ' | ' | $14.79 | $14.77 | ' | $14.77 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average fair value at grant date, options granted (in dollars per share) | ' | ' | ' | ' | $17.23 | $21.23 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average fair value at grant date, options vested (in dollars per share) | ' | ' | ' | ' | $13.95 | $16.98 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average fair value at grant date, options forfeited (in dollars per share) | ' | ' | ' | ' | $15.31 | $14.82 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average fair value at the grant date, options outstanding at the end of the period (in dollars per share) | ' | ' | ' | ' | $15.94 | $14.79 | ' | $15.94 | ' | $14.77 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total intrinsic value of stock options exercised (in dollars) | ' | ' | ' | ' | 62,893 | ' | 34,093 | 78,453 | 74,635 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total fair value of stock options vested (in dollars) | ' | ' | ' | ' | 36,939 | ' | 33,647 | 37,058 | 33,781 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total compensation cost related to non-vested options not yet recognized (in dollars) | ' | ' | ' | ' | 112,848 | ' | ' | 112,848 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average expected amortization period | ' | ' | ' | ' | ' | ' | ' | '3 years 9 months 11 days | ' | ' | ' | ' | '10 months 24 days | ' | ' | ' | ' | ' | ' | ' | ' |
Number of restricted shares issued | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 9,170 | 12,824 | ' | 17,045 | ' | ' | ' | ' | ' | ' | ' |
Weighted-average grant date fair value of restricted shares (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $95.43 | $78 | ' | $53.78 | ' | ' | ' | ' | ' | ' | ' |
Total compensation cost related to non-vested restricted shares not yet recognized (in dollars) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $781 | ' | $781 | ' | ' | ' | ' | ' | ' | ' | ' |